|
|
| MRD / Regn No. |
: THBC\23-24\09033 |
Date |
: 14/07/2026 |
| Patient Name |
: Vinesh Kumar |
Age & Gender |
: 48 Yrs. / Male |
| Contact No. |
: 9920588163 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (09/Apr/2015) | DYSLIPIDEMIA (09/Apr/2015) | HTN (09/Apr/2015) | |
|
Subjective |
: |
T2DM/HTN/DYSLIPIDEMIA SINCE 2015,PTCA - 2021,MF COMPANY,IS MENTALLY PREPARED FOR INJ SEMA,HAS TAKEN RYBELSUS IN PAST,14 MG DOSE - STOPPED BECAUSE COULD NIT TOLERATE / FLATULENCE,LOST 5 KGS OF WEIGHT |
|
Objective |
: |
13-JUL-2026 REPORTS,HB-13.2/ HBA1C-7.1%,FBS-161.54,TC-145/ TG-211/ LDL-89/ HDL-27,TSH-2.254,CR-0.69,EGFR-113 |
|
Plan |
: |
VIT D 60K WEEKLY X 3 MTHS - AFTER THAT KEEP TAKING 1 TAB EVERY 15 DAYS,VIT B12 DAILY X 2 MTHS = KEEP TAKING 2 TABS A WEEK |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET PIOGLITAZONE 15MG
PIOZ 15 MG |
ORAL |
1-0-0 |
ABF
|
3 MNTHS |
|
|
2 |
TELPVAN CT (40/12.5) |
ORAL |
1-0-0 |
ABF
|
3 MNTHS |
|
|
3 |
STATPURE CV 75/20 |
ORAL |
0-0-1 |
AD
|
3 MNTHS |
|
|
4 |
ISTAMET 1R G2 |
ORAL |
1-0-1 |
BBF / BD
|
3 MTHS |
|
|
5 |
INJ SEMASIZE 0.25 MG |
SC |
1 / WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
6 |
INJ SEMASIZE 0.5 MG |
SC |
1 / WEEKLY |
ANYTIME OF DAY
|
4 WEEKS |
|
|
7 |
INJ SEMASIZE 1 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
8 |
UPRISE D3 60,000 UNITS |
ORAL |
ONCE IN A WEEK |
ANYTIME OF DAY
|
2 MTHS |
|
|
9 |
ME 12 OD |
ORAL |
0-1-0 |
DAILY AFTER LUNCH
|
2 MTHS |
|
|
10 |
EMPANORM 25 MG |
ORAL |
1-0-0 |
ABF
|
3 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.,IF LOW SUGARS (<70 MG/DL) |
| Next Visit |
: 09/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS / PPBS ONCE IN A WEEK - 2-3 DAYS AFTER THE INJECTION TO ADJUST ORAL MEDS |
| |
|
| |
|
|
